Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemo Pharma is a prominent Egyptian pharmaceutical and medical supply company specializing in the production of life-saving solutions for renal care and intravenous therapy. Founded in 2006 and headquartered in Badr City, the company operates state-of-the-art manufacturing facilities dedicated to hemodialysis solutions, intravenous (IV) fluids, and medical disposables. Hemo Pharma serves as a critical supplier for hospitals and dialysis centers across the Middle East and North Africa (MENA) region, focusing on high-quality, affordable medical products. Their portfolio includes a wide range of IV solutions such as saline, glucose, and Ringer's lactate, alongside specialized concentrates for dialysis machines. The company is recognized for its adherence to international quality standards and its role in supporting healthcare infrastructure in emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HemoPharma.